- Conditions
- Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +6 more
- Locations
-
- Beverly Hills Cancer Center Beverly Hills, California, United States
- Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
- Hematology - Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
- University Cancer & Blood Center, LLC Athens, Georgia, United States
Clinical trial condition
Unresectable Breast Carcinoma
Explore clinical trials studying Unresectable Breast Carcinoma. Study availability and eligibility vary by location and protocol.
11 public trials
4 recruiting studies
Unresectable Breast Carcinoma trial results
NCT07137416
- Conditions
- Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, +24 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Conditions
- Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, +15 more
- Locations
-
- Keck Medicine of USC Koreatown Los Angeles, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
Recruiting
The COMPASSION Study
NCT06507930
- Conditions
- Advanced Breast Cancer, Breast Cancer, Breast Diseases, +7 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Completed
Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer
NCT01149083
- Conditions
- Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, +8 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
Active, Not Recruiting
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
NCT04616248
- Conditions
- Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Basal Cell Carcinoma, +44 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
Active, Not Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
NCT04704661
- Conditions
- Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
- Locations
-
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
Active, Not Recruiting
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer
NCT03971409
- Conditions
- Breast Diseases, Breast Neoplasms, Invasive Breast Carcinoma, +13 more
- Locations
-
- O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
- University of California, San Francisco San Francisco, California, United States
- Georgetown University Washington D.C., District of Columbia, United States
- University of Chicago Medicine Comprehensive Cancer Center Evergreen Park, Illinois, United States
Active, Not Recruiting
Onvansertib + Paclitaxel In TNBC
NCT05383196
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconness Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer
NCT04673448
- Conditions
- Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +53 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States